Not a good buy right now: price is stretched (RSI89.9 overbought) and sitting just below near-term resistance (15.90), which skews risk/reward poorly for an impatient entry.
Momentum is still positive (MACD expanding), but without proprietary buy signals and with heavy hedge-fund selling, the setup favors waiting for a dip rather than chasing.
If you must act immediately, this is more of a tactical hold/avoid-new-buy until it either cleanly breaks above ~15.90–16.34 or pulls back toward ~15.20 / ~14.50 support.
Recent coverage has been positive/upward: Susquehanna upgraded to Positive (PT $16) after MRC acquisition close; Stifel maintained Buy (PT $18); Texas Capital initiated Buy (PT $19).
Street “pros” view: larger combined platform + synergy/cross-sell + cash flow for debt reduction/returns.
Street “cons” view (implied by targets vs price): with shares at ~$15.88, you’re already near the $16 target and just below resistance, so near-term upside to consensus targets may be less compelling without a clean breakout or earnings beat.
Influential/political trading: no recent congress trading data available; insider trend reported neutral.
Wall Street analysts forecast DNOW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DNOW is 17.67 USD with a low forecast of 16 USD and a high forecast of 19 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast DNOW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DNOW is 17.67 USD with a low forecast of 16 USD and a high forecast of 19 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 16.280
Low
16
Averages
17.67
High
19
Current: 16.280
Low
16
Averages
17.67
High
19
Texas Capital
Matthew Key
initiated
$19
AI Analysis
2025-12-18
Reason
Texas Capital
Matthew Key
Price Target
$19
AI Analysis
2025-12-18
initiated
Reason
Texas Capital analyst Matthew Key initiated coverage of Dnow with a Buy rating and $19 price target. Dnow, in combination with MRC Global, is the largest global distributor of energy and industrial equipment such as pipes, valves, fittings and pumps for oil and gas, utilities and other industrial end markets, the analyst tells investors. The firm believe cost synergies and cross-selling opportunities should result in "solid" growth and cash flow generation in the coming years, the analyst added.
Stifel
Buy
maintain
$18
2025-11-24
Reason
Stifel
Price Target
$18
2025-11-24
maintain
Buy
Reason
Stifel took over lead coverage of Dnow and maintains a Buy rating and $18 price target on the shares. The firm's mid-quarter survey results strengthened compared to its prior quarterly survey with next twelve months expectations accelerating meaningfully, the analyst tells investors.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for DNOW
